Anti-mycobactrial antibiotics: Select all that apply
Isoniazid
Ethambutol
Bacitracin
a and b
a and c
Correct Answer : A,B
Mycobacterium tuberculosis is a slow-growing, acid-fast bacillus characterized by a unique, waxy cell wall rich in mycolic acids. Treatment of mycobacterial infections requires specialized antibiotics that can penetrate this complex wall and act over long periods. Combination therapy is mandatory to prevent the emergence of multidrug-resistant strains. These drugs target specific biosynthetic pathways unique to the Mycobacterium genus.
Rationale:
A. Isoniazid (INH) is a primary anti-mycobacterial agent and a prodrug that inhibits the synthesis of mycolic acids, essential components of the mycobacterial cell wall. It is highly bactericidal against rapidly dividing organisms. Patients taking INH must be monitored for hepatotoxicity and peripheral neuropathy, often requiring pyridoxine (vitamin B6) supplementation for nerve protection.
B. Ethambutol is a first-line anti-mycobacterial antibiotic that works by inhibiting arabinosyl transferase, an enzyme involved in cell wall synthesis. It is bacteriostatic and helps prevent the development of resistance to other drugs in the regimen. A key clinical consideration for ethambutol is the risk of optic neuritis, necessitating regular vision testing during treatment.
C. Bacitracin is a polypeptide antibiotic used primarily for topical skin infections caused by Gram-positive bacteria. It inhibits bacterial cell wall synthesis by interfering with dephosphorylation but is not effective against the unique lipid-rich wall of mycobacteria. It is not part of any clinical regimen for tuberculosis or other mycobacterial diseases.
D. This is correct because both isoniazid and ethambutol are classified as anti-mycobacterial agents used in the standard RIPE (Rifampin, Isoniazid, Pyrazinamide, Ethambutol) regimen. These drugs work synergistically to eradicate the pathogen from different metabolic states. Their inclusion in the treatment protocol is essential for successful patient outcomes in tuberculosis cases.
E. This choice is incorrect because it includes bacitracin, which has no activity against mycobacteria. While isoniazid is a cornerstone of anti-tubercular therapy, bacitracin's spectrum of activity is limited to superficial cutaneous or ophthalmic infections. Relying on bacitracin for mycobacterial control would lead to treatment failure and disease progression.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is E
Explanation
Beta-oxidation is the multi-stage metabolic process involving the catabolism of fatty acids within the mitochondrial matrix. Through sequential dehydration, hydration, and cleavage, long-chain acyl-CoA molecules are degraded. This yields reducing equivalents and high-energy intermediates required for ATP production via the tricarboxylic acid cycle and oxidative phosphorylation.
Rationale:
A. Citrate is the initial six-carbon intermediate formed within the cycle when a two-carbon unit condenses with oxaloacetate. While it is part of the cycle, it is not the direct entry product of fatty acid degradation. It represents a subsequent step in the aerobic processing of carbon.
B. CO2 is a gaseous metabolic byproduct released during the decarboxylation steps of the citric acid cycle. It represents the final oxidation state of carbon atoms derived from various fuels. However, it is not the molecule that transports fatty acid-derived carbons into the cycle for processing.
C. Oxaloacetate is the four-carbon substrate that must be present to accept the incoming two-carbon units from lipid metabolism. It is regenerated at the end of each cycle turn. It acts as a scaffold for oxidation rather than being the product of fatty acid breakdown itself.
D. Pyruvate is the three-carbon end-product of glycolysis, which typically undergoes oxidative decarboxylation to enter the cycle. Fatty acids are degraded two carbons at a time and bypass the pyruvate stage entirely. Therefore, pyruvate is not a metabolic product of the beta-oxidation of long-chain lipids.
E. Acetyl CoA is the primary metabolic product of fatty acid beta-oxidation. Each round of the spiral removes a two-carbon unit as acetyl CoA, which directly enters the citric acid cycle. This molecule serves as the universal intermediary linking lipid catabolism to the central energy-producing pathways of the cell.
Correct Answer is C
Explanation
The urea cycle is the primary metabolic pathway for the detoxification of ammonia generated from amino acid catabolism. Because free ammonia is highly neurotoxic, the liver converts it into a water-soluble, neutral compound suitable for renal clearance. This process is essential for maintaining nitrogen balance within the human body. Efficient excretion prevents the accumulation of toxic nitrogenous wastes that could lead to encephalopathy or systemic metabolic alkalosis.
Rationale:
A. Citrulline is an intermediate metabolite within the urea cycle itself, formed from the reaction of carbamoyl phosphate and ornithine. It is not an excretory product but a transporter of nitrogen atoms within the mitochondrial matrix and cytosol. Under normal physiological conditions, citrulline is consumed by argininosuccinate synthetase to continue the cycle. It does not represent a significant portion of urinary nitrogen output.
B. Uric acid is the final breakdown product of purine metabolism in humans. While it is excreted in the urine, it represents only a small fraction of total nitrogenous waste. Excessive levels can lead to gout or renal calculi, but it is not the primary vehicle for disposing of the vast majority of dietary nitrogen. The bulk of proteolysis products are handled through a different enzymatic pathway.
C. Urea is the principal nitrogenous constituent of urine, accounting for over 90% of nitrogen excretion in healthy adults. It is synthesized in the liver from ammonia and carbon dioxide through a sequence of five enzymatic reactions. This molecule is highly soluble and possesses a low toxicity profile, allowing it to be safely concentrated by the kidneys. It serves as the definitive marker for nitrogenous waste clearance.
D. Glutamate acts as a key intracellular nitrogen donor and a central hub for transamination reactions. It collects amino groups from various amino acids to deliver them to the urea cycle via oxidative deamination. Glutamate is vital for intracellular signaling and metabolism but is not a major excretory form of nitrogen. It is typically conserved and recycled to maintain metabolic homeostasis.
E. Ammonia is a direct product of amino acid deamination and is extremely toxic to the central nervous system. Small amounts are excreted in the urine to help regulate acid-base balance, but it is never the primary form of nitrogen disposal. The body rapidly converts the majority of ammonia into urea to avoid hyperammonemia. High levels of urinary ammonia usually indicate a response to metabolic acidosis.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
